Matinas BioPharma Holdings's three largest insider shareholders as of September 29, 2026 are Matthew Wikler (Director, 5.81K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Matthew Wikler | Director | 5,809 | 0 | 5,809 | 100.0% | 03 Jan, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Jun, 2026 | Partners Llc Sanitam | TenPercentOwner | Disposed J | 1,406 | $0.59 | $824 | 0 | Direct |
| 10 Jun, 2026 | Partners Llc Sanitam | TenPercentOwner | Disposed J | 4,798,636 | $0.64 | $3.09Mn | 0 | Direct |
| 30 Apr, 2025 | Jerome D Jabbour | President And Ceo | Acquired A | 70,100 | $0.00 | $0 | 70,100 | Direct |
| 30 Apr, 2025 | Robin L Smith | Director | Acquired A | 11,600 | $0.00 | $0 | 11,600 | Direct |
| 30 Apr, 2025 | Edward Neugeboren | Director | Acquired A | 11,600 | $0.00 | $0 | 11,600 | Direct |
| 30 Apr, 2025 | An Evelyn D | Director | Acquired A | 11,600 | $0.00 | $0 | 11,600 | Direct |
| 30 Apr, 2025 | Keith Murphy | Director | Acquired A | 11,600 | $0.00 | $0 | 11,600 | Direct |
| 15 Dec, 2023 | Theresa Matkovits | Chief Development Officer | Acquired A | 1,300,000 | $0.00 | $0 | 26,000 | Direct |
| 15 Dec, 2023 | Thomas Hoover | Chief Business Officer | Acquired A | 1,000,000 | $0.00 | $0 | 20,000 | Direct |
| 15 Dec, 2023 | Hui Liu | Chief Technology Officer | Acquired A | 1,000,000 | $0.00 | $0 | 20,000 | Direct |
| 15 Dec, 2023 | James J. Iii Ferguson | Chief Medical Officer | Acquired A | 1,200,000 | $0.00 | $0 | 24,000 | Direct |
| 15 Dec, 2023 | Keith A Kucinski | Chief Financial Officer | Acquired A | 1,000,000 | $0.00 | $0 | 20,000 | Direct |
| 15 Dec, 2023 | Jerome D Jabbour | President And Ceo | Acquired A | 3,500,000 | $0.00 | $0 | 70,000 | Direct |
| 01 Nov, 2023 | Natasha Giordano | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 01 Nov, 2023 | Eric J Ende | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 01 Nov, 2023 | Kathryn Penkus Corzo | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 01 Nov, 2023 | James S Scibetta | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 01 Nov, 2023 | Matthew Wikler | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 01 Nov, 2023 | Herbert J Conrad | Director | Acquired A | 437,244 | $0.00 | $0 | 8,745 | Direct |
| 20 Dec, 2022 | Theresa Matkovits | Chief Development Officer | Acquired A | 625,000 | $0.00 | $0 | 12,500 | Direct |